Novartis AG (NVS)
Pre-Market:
| Previous Close | 97.44 |
| Open | 97.76 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's Range | 96.86 - 97.91 |
| 52 Week Range | 92.19 - 108.78 |
| Volume | |
| Avg. Volume | 1,648,904 |
| Market Cap | 198.388B |
| Beta (5Y Monthly) | 0.47 |
| PE Ratio (TTM) | 22.07 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 3.78 (3.89%) |
| Ex-Dividend Date | Mar 07, 2024 |
| 1y Target Est | N/A |
- Zacks
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- Reuters
Morphosys says takeover by Novartis on course after report of drug safety concern
BERLIN (Reuters) -Morphosys said its takeover by Novartis is still expected to close in the first half of this year, after a news report on a possible drug safety risk knocked the German biotechnology company's stock price on Monday. Morphosys' statement came after a report by specialist website STAT News, citing two people familiar with the matter, of a safety issue with its experimental drug pelabresib, which is being developed to treat myelofibrosis, a rare type of blood cancer affecting the bone marrow.
- Zacks
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
